PTH and Hypocalcemia: As treatment progressed, the patient developed hypocalcemia, a common side effect of calcimimetics, along with persistently elevated PTH levels, prompting discontinuation of cinacalcet and introduction of calcitriol, an active vitamin D analog, to help restore calcium balance and suppress PTH secretion.